Preparation and study of the physicochemical characteristics of multilayer polymer composites based on poly(ethyleneimine)-stabilized copper nanoparticles and poly(sodium 2-acrylamide-2-methyl-1-propanesulfonate)

2021

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.15328/cb1235
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Multilayer films were synthesized from a complex of branched polyethyleneimine (PEI) with copper nanoparticles (PEI-CuNPs) and sodium poly-2-acrylamide-2-methyl-1-propanesulfonate (PAMPSNa), applied layer-by-layer (LbL) on a solid support in an acidic medium. Protonation of the amino groups of PEI in an acidic medium increases the positive charge of the PEI-CuNPs system to +43.5 mV and promotes the formation of an interpolyelectrolyte complex between the positively charged PEI-CuNPs and the highly charged anionic polyelectrolyte PAMPS, the ζ-potential of which was -141 mV. AFM images and SEM micrographs showed a uniform distribution of spherical copper nanoparticles in the homogeneous structure of the multilayer film. The optical characteristics and hydrodynamic dimensions of PEI-CuNPs indicate the formation of PEI-CuNPs nanoparticles with sizes of 60-300 nm, with an average size of up to 100 nm. Copper nanoparticles distributed uniformly in a multilayer PEI-CuNPs/PAMPS film may be of interest for applications in the field of membrane catalysis, biochips, sensor membranes, and controlled drug delivery.